CLINICAL_TRIALS
trial_result
· 2022-06-07
Clinical Trial Update: Sunitinib for Advanced Thymus Cancer Following Earlier Treatment [Phase 2]
Summary
A Phase 2 trial evaluating sunitinib in advanced thymus cancers (thymoma and thymus neoplasms) has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Thymoma, Thymus Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2022-06-07